Xarelto

J&J Drug Treats Lung Clots With Less Bleeding, Study Finds
Bloomberg
Mon, 03/26/12 - 11:10 am
JNJ
lung clots
Bayer
Xarelto
bloodthinners
Bayer, J&J clot drug to get fast FDA review for ACS
Reuters
Tue, 02/28/12 - 10:05 am
Bayer
FDA
JNJ
Xarelto
fast track
acute coronary syndrome
Replacing Coumadin: A $10 Billion Opportunity
Seeking Alpha
Mon, 02/13/12 - 07:58 pm
Coumadin
Eliquis
Pfizer
Apixaban
Bristol-Myers Squibb
Xarelto
Bayer
JNJ
Pradaxa
Boehringer Ingelheim
Bayer expects China approval for stroke drug Xarelto
Reuters
Thu, 02/9/12 - 09:30 am
Bayer
China
Xarelto
UK cost agency wants more data on Bayer anti-clot drug
Reuters
Mon, 01/9/12 - 09:52 am
UK
Bayer
Xarelto
Bayer Seeks to Expand Xarelto's Label
Yahoo/Zacks.com
Tue, 01/3/12 - 10:45 am
Bayer
Xarelto
anti-clotting
Johnson & Johnson seeks FDA approval for third use for its new anticlotting drug, Xarelto
Yahoo/AP
Thu, 12/29/11 - 11:52 am
JNJ
FDA
anti-clotting
Xarelto
Bayer predicts blockbuster success for four of its late-stage drugs
Fierce Biotech
Tue, 12/20/11 - 11:24 am
Bayer
Xarelto
VEGF Trap-Eye
regorafenib
Alpharadin
Bayer wins EU approval for stroke drug Xarelto
Reuters
Mon, 12/19/11 - 08:25 am
Bayer
Europe
Xarelto
bloodthinners
Doctors reserve judgement on new blood clot drugs
Reuters
Tue, 11/15/11 - 12:36 pm
physicians
bloodthinners
Apixaban
Xarelto
Pradaxa
Bayer
Boehringer Ingelheim
JNJ
Pfizer
Bristol-Myers Squibb
J&J-Bayer Blood Thinner May Enter $1B Market
Bloomberg
Mon, 11/14/11 - 10:46 am
bloodthinners
JNJ
Bayer
Xarelto
ATLAS ACS 2-TIMI 51: Rivaroxaban Beneficial in Low-Risk ACS Population
Forbes
Sun, 11/13/11 - 12:15 pm
rivaroxaban
Xarelto
acute coronary syndrome
anticoagulants
anti-platelets
Bayer Shares Rise 4% After Xarelto Wins U.S. FDA Approval
Bloomberg
Mon, 11/7/11 - 09:24 am
FDA
Bayer
Xarelto
bloodthinners
Rivaroxaban Roundup: NEJM Perspective on FDA Panel, ATLAS-ACS Will Be an AHA Late-Breaker
Forbes
Thu, 10/6/11 - 09:18 am
FDA
rivaroxaban
Xarelto
Bayer
JNJ
Rivaroxaban Meets Primary Endpoint in ATLAS ACS TIMI 51
Forbes
Fri, 09/30/11 - 09:26 am
rivaroxaban
JNJ
Xarelto
acute coronary syndrome
Bayer
Johnson & Johnson's Xarelto Not a Cure for Pipeline Concerns
Seeking Alpha
Sun, 09/25/11 - 01:05 pm
JNJ
Xarelto
Bayer’s Xarelto Wins EU Drug Panel Backing for Added Use
Bloomberg
Fri, 09/23/11 - 08:55 am
Bayer
bloodthinners
Xarelto
Europe
The Rivaroxaban (Xarelto) FDA Panel and Large Pragmatic Trials
Forbes
Sat, 09/10/11 - 10:25 am
Xarelto
JNJ
anti-clotting
atrial fibrillation
FDA
Anti-Clotting Stumble For J&J/Bayer Likely to Help Pfizer/Bristol-Meyers
Seeking Alpha
Fri, 09/9/11 - 11:36 am
JNJ
Bayer
Pfizer
Bristol-Myers Squibb
Xarelto
Citi analyst expects FDA approval of J&J anticlotting drug after committee recommendatio
Yahoo/AP
Fri, 09/9/11 - 11:23 am
FDA
JNJ
Xarelto
bloodthinners
Bayer

Pages